Munich, 29th October 2018. Attorney Rolf G. Pohlmann was able to sell Genomatix AG to a listed market leader within the biotech industry from outside Europe in the course of a transferred restructuring.Weiter lesen
ORPEA’S POSITION IN PREMIUM NURSING HOMES IN GERMANY STRENGTHENED WITH ACQUISITION OF 7 FACILITIES AND SET-UP OF A DEDICATED JOINT VENTURE
Frankfurt, 7th November 2018. The ORPEA group, a world leader in long-term care (nursing homes, post-acute and rehabilitation hospitals, psychiatric hospitals, and homecare services), announced the acquisition of Axion group in Germany.
ACXIT Capital Partners, represented by Thomas Klack and his team, acted as exclusive financial advisor to ORPEA in this transaction. The parties agreed not to disclose any details of the transaction.
Frankfurt, 6th November 2018. The publicly traded French Software as a Service (SaaS) company Oxatis is taking over Channel Pilot Solutions GmbH, with its product data management tool, to further extend its technological lead and accelerate growth in Europe. ACXIT Capital Partners (in cooperation with PAX Corporate Finance) acted as the exclusive M&A advisor to Channel Pilot Solutions GmbH and its shareholders.
London, 28 November 2018. ACXIT’s partner FirstCapital advised on the completion of a secondary management buyout funded by Ethos Partners and Santander, ensuring new backing for Miles 33’s next phase of growth.Weiter lesen
ACXIT Capital Partners exclusively advises casualfood GmbH and its shareholders on the strategic partnership with ORIOR AG
Frankfurt, 26th October 2018. ACXIT Capital Partners exclusively advises casualfood GmbH (“casualfood”), one of Germany’s leading operators of innovative travel catering concepts, and its shareholders on the strategic partnership with Swiss food and beverage group ORIOR AG (“ORIOR”).
ACXIT Capital Partners advises medpex on the trade sale of its e-commerce activities to Zur Rose Group
- Link between mail-order activities of medpex and Zur Rose subsidiary DocMorris
- Additional growth opportunities due to outstandingly complementary activities
- The founders and managers of medpex will continue to lead the activities and will become shareholders in the Zur Rose Group AG
Ludwigshafen, 18 October 2018. medpex, the third biggest online pharmacy in Germany, is bundling its activities with Swiss company Zur Rose Group AG. With this step, medpex is setting the basis to continue its successful growth trajectory at a high pace in the future and play a proactive role in market consolidation. The outstandingly complementary activities of medpex and Zur Rose subsidiary DocMorris create additional growth opportunities for both companies. Customers will benefit from an even broader product range and from additional services. The founders and managers of medpex will also become shareholders in Zur Rose Group AG as part of the transaction.Weiter lesen
London, 09 October 2018. ACXIT’s partner FirstCapital advised CoScale on the sale to New Relic.Weiter lesen
ACXIT CAPITAL PARTNERS EXCLUSIVELY ADVISES WICKEDER WESTFALENSTAHL ON MANAGEMENT BUY-OUT OF DEUTSCHE NICKEL GROUP
Frankfurt, 03 August 2018. ACXIT Capital Partners exclusively advised Wickeder Westfalenstahl GmbH, one of the world’s leading manufacturers of clad flat products, on the Management Buy-Out (MBO) of Deutsche Nickel Group.Weiter lesen
London, 26 June 2018. ACXIT’s partner FirstCapital advised Bloomsbury.ai joining Facebook.